Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1983 Mar;49:141–145. doi: 10.1289/ehp.8349141

Genotoxicity of N-acetylarylamines in the Salmonella/hepatocyte system

Snorri S Thorgeirsson, Leonard C Erickson, Carole L Smith, Irene B Glowinski
PMCID: PMC1569138  PMID: 6339222

Abstract

Coincubation of isolated, intact rat hepatocytes with Salmonella typhimurium tester strain TA 98 (Salmonella/hepatocyte system) has been employed to determine both bacterial mutagenicity and DNA damage in the hepatocytes following treatment with 2-acetylaminofluorene (AAF) and other AAF derivatives. In vivo pretreatment of rats with either 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD) or 3-methylcholanthrene (MC) markedly increased both DNA damage and bacterial mutation frequency upon incubation of AAF or 2-aminofluorene (AF), in this system. The increase in damage to the hepatocyte-DNA was more pronounced after AAF treatment than by that for AF, while the increase in bacterial mutation frequency was greater after AF treatment. Hepatocytes treated with paraoxon prior to exposure to N-hydroxy-2-acetylaminofluorene (N-OH-AAF) or N-acetoxy-2-acetylaminofluorene (N-OAc-AAF) partially inhibited the DNA damage caused by these agents, as well as inhibiting the bacterial mutagenicity of N-OAc-AAF (50% inhibition) and N-OH-AAF (80% inhibition). These data indicate that metabolic processes other than those involved in activating AAF and its derivatives into a bacterial mutagen(s) may contribute to the genotoxic effects of these compounds. Thus, the Salmonella/hepatocyte system may provide a useful model in which to study the relative role of the various metabolic processes associated with the carcinogenic effects of N-acetylarylamines.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 Dec;31(6):347–364. doi: 10.1016/0165-1161(75)90046-1. [DOI] [PubMed] [Google Scholar]
  2. Erickson L. C., Osieka R., Sharkey N. A., Kohn K. W. Measurement of DNA damage in unlabeled mammalian cells analyzed by alkaline elution and a fluorometric DNA assay. Anal Biochem. 1980 Jul 15;106(1):169–174. doi: 10.1016/0003-2697(80)90133-5. [DOI] [PubMed] [Google Scholar]
  3. Farber E., Cameron R. The sequential analysis of cancer development. Adv Cancer Res. 1980;31:125–226. doi: 10.1016/s0065-230x(08)60658-2. [DOI] [PubMed] [Google Scholar]
  4. Kohn K. W., Erickson L. C., Ewig R. A., Friedman C. A. Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry. 1976 Oct 19;15(21):4629–4637. doi: 10.1021/bi00666a013. [DOI] [PubMed] [Google Scholar]
  5. Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res. 1978 Jun;38(6):1479–1496. [PubMed] [Google Scholar]
  6. Razzouk C., Mercier M., Roberfroid M. Induction, activation, and inhibition of hamster and rat liver microsomal arylamide and arylamine N-hydroxylase. Cancer Res. 1980 Oct;40(10):3540–3546. [PubMed] [Google Scholar]
  7. Sakai S., Reinhold C. E., Wirth P. J., Thorgeirsson S. S. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse. Cancer Res. 1978 Jul;38(7):2058–2067. [PubMed] [Google Scholar]
  8. Schut H. A., Wirth P. J., Thorgeirsson S. S. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. Mol Pharmacol. 1978 Jul;14(4):682–692. [PubMed] [Google Scholar]
  9. Smith C. L., Thorgeirsson S. S. An improved high-pressure liquid chromatographic assay for 2-acetylaminofluorene and eight of its metabolites. Anal Biochem. 1981 May 1;113(1):62–67. doi: 10.1016/0003-2697(81)90044-0. [DOI] [PubMed] [Google Scholar]
  10. Staiano N., Erickson L. C., Thorgeirsson S. S. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system. Biochem Biophys Res Commun. 1980 Jun 16;94(3):837–842. doi: 10.1016/0006-291x(80)91310-8. [DOI] [PubMed] [Google Scholar]
  11. Thorgeirsson S. S., Nebert D. W. The Ah locus and the metabolism of chemical carcinogens and other foreign compounds. Adv Cancer Res. 1977;25:149–193. doi: 10.1016/s0065-230x(08)60634-x. [DOI] [PubMed] [Google Scholar]
  12. Weeks C. E., Allaben W. T., Louie S. C., Lazear E. J., King C. M. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. Cancer Res. 1978 Mar;38(3):613–618. [PubMed] [Google Scholar]
  13. Wirth P. J., Thorgeirsson S. S. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver. Mol Pharmacol. 1981 Mar;19(2):337–344. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES